Clinical Trial Update: Study of ANAVEX2-73 in Patients With Rett Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ANAVEX2-73 in Rett syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• ANAVEX2-73 (blarcamesine)

Snippet

Sponsor: Anavex Life Sciences Corp. | Conditions: Rett Syndrome | Phase 2 | Status: COMPLETED